合作提案
Charsire has been devoted to research cell regeneration, and has now already developed four botanic drugs into different phases, which are the diabetic wound healing new drug CSTC1, dermatitis drug EZH1, adjuvant drug ANT1 for cancer radiation therapy, and the hair follicle regeneration drug GHA1.
Charsire cell regeneration technology was certificated the patent for medical invention in U.S. in 2006, and until 2013 has obtained the patent in 15 countries, including Europe Union, Japan, China, Taiwan, Australia…etc. In 2006, additionally, we launched new brands, sfons and Angastar, for cell regeneration of skin and health care, and were greatly responded by the consumers. 
To furthermore understand about Charsire, including information, project or business cooperation, and agency, please mail to cyweng@charsire.com.tw